Literature DB >> 7907864

The aminopeptidase activity in the human T-cell lymphoma line (Jurkat) is not at the cell surface and is not aminopeptidase N (CD-13).

H Murray1, A J Turner, A J Kenny.   

Abstract

Although lymphocytes are CD-13-negative and therefore should not express the ectoenzyme aminopeptidase N (AP-N), there have been a number of reports suggesting the presence of a cell-surface aminopeptidase with many similarities to AP-N. We have determined aminopeptidase activity with 4-methyl-7-coumarylamide (NMec) derivatives of alanine, leucine, lysine and arginine in Jurkat cells (a human T-cell lymphoma line) and in HL60 cells (a CD-13-positive myeloid leukaemia line) and compared the activities with those of purified pig AP-N and human renal microvillar membranes. Jurkat cell aminopeptidase activity doubled on disrupting the cells and the sensitivity to amastatin increased. When the cells were fractionated only 4% of the activity was recovered in the membrane fraction, compared with 87% recovery for alkaline phosphatase. The profile of activities for intact Jurkat cells was Leu > Ala > Lys > Arg, changing in the cytosolic fraction to Lys > or = Arg > Leu = Ala; the profiles for intact HL60 cells and AP-N were identical, namely Ala > Leu > Arg > Lys. The Km values for the hydrolysis of Ala-NMec and Leu-NMec by Jurkat cells were 65 microM and 11 microM, in each case some 6-fold lower than those for AP-N. The pH-activity curves for the hydrolysis of Ala-NMec by Jurkat cells and human renal microvillar membranes were displaced by almost 1 pH unit and the activity was not sensitive to the anionic composition of the buffers. However, a 3-fold activation of the cytosolic activity by 0.1 M NaCl was observed with Arg-NMec as substrate. With Ala-NMec as substrate, the sensitivity of the aminopeptidase activity to inhibitors increased markedly after disrupting the cells, but still differed from that observed with purified pig AP-N; the concentrations giving 50% inhibition were as follows (values for AP-N in parentheses): amastatin. 28 nM (150 nM); bestatin, 12 microM (43 microM), probestin, 100 nM (< 10 nM), puromycin, 30 microM (> 1 mM). Anion exchange chromatography on Mono Q revealed two activities: that of peak I preferentially hydrolysed Arg-NMec, was activated by NaCl and was insensitive to amastatin; while that of peak II was strongly inhibited by amastatin and had a broad specificity.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907864      PMCID: PMC1137947          DOI: 10.1042/bj2980353

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Bestatin inhibits covalent coupling of [3H]LTA4 to human leukocyte LTA4 hydrolase.

Authors:  J F Evans; S Kargman
Journal:  FEBS Lett       Date:  1992-02-03       Impact factor: 4.124

2.  Leukotriene A4 hydrolase is a zinc-containing aminopeptidase.

Authors:  M Minami; N Ohishi; H Mutoh; T Izumi; H Bito; H Wada; Y Seyama; H Toh; T Shimizu
Journal:  Biochem Biophys Res Commun       Date:  1990-12-14       Impact factor: 3.575

3.  Membrane-bound peptidases of lymphocytes: functional implications.

Authors:  S Ansorge; E Schön; D Kunz
Journal:  Biomed Biochim Acta       Date:  1991

4.  Types and localization of aminopeptidases in different human blood cells.

Authors:  M Grdisa; L Vitale
Journal:  Int J Biochem       Date:  1991

5.  Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes.

Authors:  L Orning; G Krivi; F A Fitzpatrick
Journal:  J Biol Chem       Date:  1991-01-25       Impact factor: 5.157

6.  Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril.

Authors:  L Orning; G Krivi; G Bild; J Gierse; S Aykent; F A Fitzpatrick
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

7.  Leukotriene A4 hydrolase: an anion activated peptidase.

Authors:  A Wetterholm; J Z Haeggström
Journal:  Biochim Biophys Acta       Date:  1992-02-12

8.  Aminopeptidase A activity of the murine B-lymphocyte differentiation antigen BP-1/6C3.

Authors:  Q Wu; L Li; M D Cooper; M Pierres; J P Gorvel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

9.  CD26 antigen is a surface dipeptidyl peptidase IV (DPPIV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1C7.

Authors:  A J Ulmer; T Mattern; A C Feller; E Heymann; H D Flad
Journal:  Scand J Immunol       Date:  1990-04       Impact factor: 3.487

10.  A highly sensitive E.L.I.S.A. for endopeptidase-24.11, the common acute-lymphoblastic-leukaemia antigen (CALLA, CD-10), applicable to material of porcine and human origin.

Authors:  S Howell; H Murray; C S Scott; A J Turner; A J Kenny
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

View more
  4 in total

1.  Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.

Authors:  U Lendeckel; T Wex; D Reinhold; T Kähne; K Frank; J Faust; K Neubert; S Ansorge
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

2.  The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme.

Authors:  Yasuhiro Tsume; Gordon L Amidon
Journal:  Molecules       Date:  2012-03-26       Impact factor: 4.411

Review 3.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

4.  The main neutral aminopeptidase activity of human lymphoid tumour cell lines does not originate from the aminopeptidase N-(APN; CD13) gene.

Authors:  T Wex; U Lendeckel; T Kähne; A Ittenson; K Frank; S Ansorge
Journal:  Biochim Biophys Acta       Date:  1997-02-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.